Literature DB >> 17464449

Hepatocyte growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells.

Sheng-hua Chu1, Yan-bin Ma, Hong Zhang, Dong-fu Feng, Zhi-an Zhu, Zhi-qiang Li, Xian-hou Yuan.   

Abstract

Hepatocyte growth factor (HGF) is a pleiotrophic cytokine that stimulates motility and invasion of several cancer cell types and induces angiogenesis, which is known to be expressed in several malignancies including glioma. The effect of transforming growth factor-beta (TGF-beta) isoforrns as well as gangliosides on HGF production was investigated in human glioma cell lines. TGF-beta isoforms and gangliosides were found to differentially stimulate HGF production by these cells. The ganglioside GD3 enhanced this release to the greatest extent and the stimulation was more marked in a glioblastoma cell line than in the two other anaplastic astrocytoma cell lines. These results suggest that both TGF-betas and gangliosides may act as indirect angiogenic factors by stimulating HGF secretion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17464449     DOI: 10.1007/s11060-007-9387-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  46 in total

1.  TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.

Authors:  Günter Eisele; Jörg Wischhusen; Michel Mittelbronn; Richard Meyermann; Inja Waldhauer; Alexander Steinle; Michael Weller; Manuel A Friese
Journal:  Brain       Date:  2006-08-03       Impact factor: 13.501

2.  In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides.

Authors:  Sheng-hua Chu; Zhi-an Zhu; Xian-hou Yuan; Zhi-qiang Li; Pu-cha Jiang
Journal:  J Neurooncol       Date:  2006-04-29       Impact factor: 4.130

3.  Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas.

Authors:  J D Stiles; P T Ostrow; L L Balos; S J Greenberg; R Plunkett; W Grand; R R Heffner
Journal:  J Neuropathol Exp Neurol       Date:  1997-04       Impact factor: 3.685

4.  Different angiogenic phenotypes in primary and secondary glioblastomas.

Authors:  Sibylle Karcher; Hans-Herbert Steiner; Rezvan Ahmadi; Saida Zoubaa; Gergely Vasvari; Harry Bauer; Andreas Unterberg; Christel Herold-Mende
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

5.  [The expression of hepatocyte growth factor and its receptor in brain astrocytomas].

Authors:  Sheng-Hua Chu; Xian-Hou Yuan; Pu-Cha Jiang; Zhi-Qiang Li; Jie Zhang; Zhi-Hua Wen; Shi-Yu Zhao; Xin-Jun Chen; Chang-Jun Cao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-03-30

6.  Vascular and perivascular GD3 expression in human glioma.

Authors:  S Koochekpour; G J Pilkington
Journal:  Cancer Lett       Date:  1996-06-24       Impact factor: 8.679

7.  Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro.

Authors:  S Koochekpour; A Merzak; G J Pilkington
Journal:  Cancer Lett       Date:  1996-04-19       Impact factor: 8.679

Review 8.  Breast carcinoma: a collective disorder.

Authors:  S Byers; M Park; C Sommers; S Seslar
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Gangliosides promote the angiogenic response.

Authors:  M Ziche; G Alessandri; P M Gullino
Journal:  Lab Invest       Date:  1989-12       Impact factor: 5.662

10.  ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression.

Authors:  Andreas Lux; Fiona Salway; Holly K Dressman; Gabriele Kröner-Lux; Mathias Hafner; Philip J R Day; Douglas A Marchuk; John Garland
Journal:  BMC Cardiovasc Disord       Date:  2006-04-04       Impact factor: 2.298

View more
  8 in total

1.  The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival.

Authors:  Qing-le Liang; Zheng-ying Mo; Ping Wang; Xiao Li; Zhi-xiang Liu; Zhang-ming Zhou
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

2.  HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion.

Authors:  Kristina E Hoot; Masako Oka; Gangwen Han; Erwin Bottinger; Qinghong Zhang; Xiao-Jing Wang
Journal:  J Clin Invest       Date:  2010-09-13       Impact factor: 14.808

3.  Stroke Induces Mesenchymal Stem Cell Migration to Infarcted Brain Areas Via CXCR4 and C-Met Signaling.

Authors:  Oh Young Bang; Gyeong Joon Moon; Dong Hee Kim; Ji Hyun Lee; Sooyoon Kim; Jeong Pyo Son; Yeon Hee Cho; Won Hyuk Chang; Yun-Hee Kim
Journal:  Transl Stroke Res       Date:  2017-05-25       Impact factor: 6.829

4.  Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.

Authors:  Purna Mukherjee; Anthony C Faber; Laura M Shelton; Rena C Baek; Thomas C Chiles; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2008-02-20       Impact factor: 5.922

5.  Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1.

Authors:  Sheng-Hua Chu; Dong-Fu Feng; Yan-Bin Ma; Zhi-An Zhu; Hong Zhang; Jian-Hua Qiu
Journal:  Mol Biol Rep       Date:  2008-11-02       Impact factor: 2.316

6.  c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro.

Authors:  Sheng-Hua Chu; Dong-Fu Feng; Hong Zhang; Er-Tao Chen; Zhi-Xin Duan; Xue-Yuan Li; Jia Li; Yan-Bin Ma; Zhi-An Zhu; Jian-Hua Qiu
Journal:  J Neurooncol       Date:  2009-01-24       Impact factor: 4.130

Review 7.  The molecular profile of microglia under the influence of glioma.

Authors:  Wei Li; Manuel B Graeber
Journal:  Neuro Oncol       Date:  2012-05-09       Impact factor: 12.300

8.  Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells.

Authors:  Chia Chu; Donald P Bottaro; Michael J Betenbaugh; Joseph Shiloach
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.